cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Alx Oncology Holdings Inc
1 own
1 watching
Current Price
$0
$-0.34
(-3.68%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
376.11M
52-Week High
52-Week High
20.4
52-Week Low
52-Week Low
5.82
Average Volume
Average Volume
0.06M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization376.11M
icon52-Week High20.4
icon52-Week Low5.82
iconAverage Volume0.06M
iconDividend Yield--
iconP/E Ratio--
What does the Alx Oncology Holdings Inc do?
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hodgkin s lymphoma, as well as a range of solid tumor indications, including head and neck squamous cell carcinoma, human epidermal growth factor receptor 2 (HER2) positive gastric/gastroesophageal junction carcinoma, HER2-expressing breast cancer, and other solid tumors. The company's pre-clinical products include ALTA-002, a SIRPa TRAAC that offers ways to engage the innate and adaptive immune response to cancer. ALX Oncology Holdings Inc. has a collaboration agreement with Merck for a Phase 2 trial evaluating ALX148 in combination with pembrolizumab with and without chemotherapy in patients with head and neck cancer; Zymeworks on a Phase 1 trial evaluating ALX148 with the HER2-targeting bispecific antibody zanidatamab in patients with HER2-expressing breast cancer and other solid tumors; and Tallac Therapeutics for the development, manufacturing and commercialization of a novel class of cancer immunotherapeutics. It also has a license agreement with Selexis SA and Crystal Bioscience, Inc. The company was founded in 2015 and is headquartered in South San Francisco, California.
Read More
How much money does Alx Oncology Holdings Inc make?
News & Events about Alx Oncology Holdings Inc.
Globe Newswire
29days ago
SOUTH SAN FRANCISCO, Calif., Jan. 05, 2023 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (ALX Oncology) (Nasdaq: ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today provided a corporate update and highlighted key milestones anticipated...
Globe Newswire
1month ago
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (ALX Oncology) (Nasdaq: ALXO), a clinical-stage immuno-oncology company developing therapies to block the CD47 checkpoint pathway, today announced that Jaume Pons, Ph.D., Founder, President and Chief Executive...
Globe Newswire
1month ago
-- Antileukemic activity demonstrated in patients with both relapsed/refractory and newly diagnosed AML-- No evorpacept-related cytopenias observed and no maximum tolerated dose identified in combination with azacitidine and venetoclax -- ALX Oncology to Host Conference Call on December 13th at 7:30...
Globe Newswire
3 months ago
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (ALX Oncology) (Nasdaq: ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today announced the Company will be presenting clinical data from the dose ...
Globe Newswire
4 months ago
SOUTH SAN FRANCISCO, Calif., Oct. 05, 2022 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (ALX Oncology) (Nasdaq: ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today announced the acceptance of two Trials in Progress abstracts related ...
Frequently Asked Questions
Frequently Asked Questions
What is Alx Oncology Holdings Inc share price today?
plus_minus_icon
Can Indians buy Alx Oncology Holdings Inc shares?
plus_minus_icon
How can I buy Alx Oncology Holdings Inc shares from India?
plus_minus_icon
Can Fractional shares of Alx Oncology Holdings Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Alx Oncology Holdings Inc stocks?
plus_minus_icon
What is today’s traded volume of Alx Oncology Holdings Inc?
plus_minus_icon
What is today’s market capitalisation of Alx Oncology Holdings Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Alx Oncology Holdings Inc?
plus_minus_icon
What percentage is Alx Oncology Holdings Inc down from its 52-Week High?
plus_minus_icon
What percentage is Alx Oncology Holdings Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$-0.34
(-3.68%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00